AAAAAA
Results:
1-9
|
Results: 9
Authors:
Sersa, G
Stabuc, B
Cemazar, M
Miklavcic, D
Rudolf, Z
Citation: G. Sersa et al., Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients, CLIN CANC R, 6(3), 2000, pp. 863-867
Authors:
Sersa, G
Stabuc, B
Cemazar, M
Miklavcic, D
Rudolf, Z
Citation: G. Sersa et al., Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases, MELANOMA RE, 10(4), 2000, pp. 381-385
Authors:
Ocvirk, J
Stabuc, B
Rudolf, Z
Galvani, V
Curin-Serbec, V
Citation: J. Ocvirk et al., Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients, MELANOMA RE, 10(3), 2000, pp. 253-258
Authors:
Hajdinjak, T
Jeras, M
Knezevic, M
Stabuc, B
Citation: T. Hajdinjak et al., In vitro functional tests for evaluation of stimulating capacity of cultured human dendritic cells, PFLUG ARCH, 440(5), 2000, pp. R49-R50
Authors:
Galvani, V
Hartman, KP
Rupreht, RR
Novakovic, S
Stabuc, B
Ocvirk, J
Menart, V
Porekar, VG
Stale, A
Rozman, P
Serbec, VC
Citation: V. Galvani et al., Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population, PFLUG ARCH, 440(5), 2000, pp. R61-R63
Authors:
Stabuc, B
Markovic, A
Plesnicar, A
Cizej, TE
Citation: B. Stabuc et al., Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer, NEOPLASMA, 47(4), 2000, pp. 248-252
Authors:
Bartenjev, I
Rudolf, Z
Stabuc, B
Vrhovec, I
Perkovic, T
Kansky, A
Citation: I. Bartenjev et al., Cathepsin D expression in early cutaneous malignant melanoma, INT J DERM, 39(8), 2000, pp. 599-602
Authors:
Stabuc, B
Vrhovec, L
Stabuc-Silih, M
Cizej, TE
Citation: B. Stabuc et al., Improved prediction of decreased creatinine clearance by serum cystatin C:Use in cancer patients before and during chemotherapy, CLIN CHEM, 46(2), 2000, pp. 193-197
Authors:
Kos, J
Stabuc, B
Cimerman, N
Brunner, N
Citation: J. Kos et al., Serum cystatin C, a new marker of glomerular filtration rate, is increasedduring malignant progression, CLIN CHEM, 44(12), 1998, pp. 2556-2557
Risultati:
1-9
|